Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 5440

New York, NY 10029

Study Summary:

There is emerging evidence that Ketamine may have rapid antidepressant properties for patients with severe mood disorders. In this study we are investigating whether Ketamine can have an antidepressant effect compared to Midazolam. The study period will last up to 6 weeks, depending on your response to the study medication. There are two required overnight stays.

Qualified Participants Must:

• Be 21-80 years of age
• Have been given a diagnosis of Major Depressive Disorder
• Not have responded to past treatments

Qualified Participants May Receive:

Study-related care and study medication at no cost, and will be reimbursed for participation.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.